The following new drugs and formulations might become available in 2019/20.
Learning about new research shows how your care might change in the future.
How quickly these drugs become available in the UK will depend on several factors.
Many people are interested in ART that uses injections rather than pills.
These two long-acting drugs might mean ART can come from having subcutaneous injections (under the skin, not into a vein) every 1-2 months.
If approved, this option might become available in the UK in 2020/21.
It is already being used by people who are unable to use pill-based ART.
Islatravir is a new type of nuke that is being studied for HIV treatment and for prevention (PrEP).
It is being used in combination with the NNRTI doravirine and might be included in UK studies over the next year.
Last updated: 1 October 2019.